These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen. Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073 [TBL] [Abstract][Full Text] [Related]
5. Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase. Papp-Wallace KM; Becka SA; Taracila MA; Winkler ML; Gatta JA; Rholl DA; Schweizer HP; Bonomo RA Antimicrob Agents Chemother; 2016 Feb; 60(2):777-88. PubMed ID: 26596949 [TBL] [Abstract][Full Text] [Related]
6. Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria. Somprasong N; Hall CM; Webb JR; Sahl JW; Wagner DM; Keim P; Currie BJ; Schweizer HP mBio; 2020 Apr; 11(2):. PubMed ID: 32291300 [No Abstract] [Full Text] [Related]
7. Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases. Degrossi JJ; Merino C; Isasmendi AM; Ibarra LM; Collins C; Bo NE; Papalia M; Fernandez JS; Hernandez CM; Papp-Wallace KM; Bonomo RA; Vazquez MS; Power P; Ramirez MS Curr Microbiol; 2019 Apr; 76(4):485-494. PubMed ID: 30783798 [TBL] [Abstract][Full Text] [Related]
8. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
9. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276. Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511 [TBL] [Abstract][Full Text] [Related]
10. Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Zeiser ET; Becka SA; Barnes MD; Taracila MA; LiPuma JJ; Papp-Wallace KM Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718248 [No Abstract] [Full Text] [Related]
11. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei. Keith KE; Oyston PC; Crossett B; Fairweather NF; Titball RW; Walsh TR; Brown KA Antimicrob Agents Chemother; 2005 Apr; 49(4):1639-41. PubMed ID: 15793160 [TBL] [Abstract][Full Text] [Related]
13. Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del. Yi H; Kim K; Cho KH; Jung O; Kim HS Antimicrob Agents Chemother; 2012 Jul; 56(7):4005-8. PubMed ID: 22564834 [TBL] [Abstract][Full Text] [Related]
15. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396 [TBL] [Abstract][Full Text] [Related]
16. EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity. Wagner UG; Petersen EI; Schwab H; Kratky C Protein Sci; 2002 Mar; 11(3):467-78. PubMed ID: 11847270 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Trépanier S; Prince A; Huletsky A Antimicrob Agents Chemother; 1997 Nov; 41(11):2399-405. PubMed ID: 9371340 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance. Chirakul S; Norris MH; Pagdepanichkit S; Somprasong N; Randall LB; Shirley JF; Borlee BR; Lomovskaya O; Tuanyok A; Schweizer HP Sci Rep; 2018 Jul; 8(1):10652. PubMed ID: 30006637 [TBL] [Abstract][Full Text] [Related]
19. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Tribuddharat C; Moore RA; Baker P; Woods DE Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450 [TBL] [Abstract][Full Text] [Related]
20. Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex. Poirel L; Rodriguez-Martinez JM; Plésiat P; Nordmann P Antimicrob Agents Chemother; 2009 Mar; 53(3):876-82. PubMed ID: 19075063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]